Southridge LLC ("Southridge"), an investment firm that provides financing to small-cap and micro-cap companies, is pleased to announce that its affiliated fund has closed a private agreement which can provide up to $15 million in equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS).
Sword Diagnostics, Inc. is pleased to announce that the United States Patent Office (USPTO) has issued patent number 7,599,057 titled "Method and Apparatus for Detection of Biological Organisms using Raman Scattering" to the company. The patent covers the core technology which focuses on improved sensitivity.
The Eye-POD Eye Care Kit has just been created by an entrepreneurial R&D company in Florida, Hot Ideas World, Inc.
Joint project between PTB and its US counterpart NIST might advance simple and cost effective diagnostical methods
In addition to ageing demographics and higher incidence of vision disorders, key factors underpinning demand for ophthalmic instrumentation include development of innovative technologies and procedures, especially in vision correction surgery, growing recognition of laser surgery, and the trend towards permanent visual correction. The surgical vision correction market is set to change with continuing acceptance of customized ablation, wavefront analysis technology, and intralase technology. Treatment of cataracts is one of the most important segments of the ophthalmic surgical devices market. Extraction of cataract and IOL implantation is one of the most widely performed procedures in the western world.
The US markets for ear, nose, and throat (ENT) and bronchoscopy devices will grow moderately through 2013. The ENT market will be far larger than the market for bronchoscopy devices and will also expand more rapidly, reaching a value of more than $360 million dollars by 2013.
Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) today announced that The Helen F. Graham Cancer Center associated with Christiana Care Health System, a screening site for the International Early Lung Cancer Program (I-ELCAP), will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath® assay, an early-stage diagnostic test for lung cancer.
Ophthonix, the innovators who introduced non-surgical high definition vision technology to the market so that consumers have crisper, clearer and more vivid vision than ever before, today announced the launch of customized iZon® SL(TM) Polarized Lenses. The new iZon SL Polarized Lenses provide wearers with high definition vision, or WOW vision, in sunlight glare, even when reflected off water, land, ice and snow. The iZon SL Polarized Lens is designed for those consumers who want a level of vision that will maximize their performance and enjoyment in their favorite daytime outdoor activities, whatever the season. The new lens can even help in reduced contrast conditions.
A Southern California fetal surgery institute, one of only a handful in the United States, has posted enormously successful rates in treating a dangerous disorder that affects 10 percent of unborn identical twins.
Hexagon has recently acquired all outstanding assets and intellectual property of two German companies within the vision metrology industry. The acquisitions will further enhance Hexagon’s worldwide product offering in multisensor vision technology.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.